Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

Heritage Bio Labs

Research Library

Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.

Browse by productGeneral topics

Find articles

Matching articles

Showing 49–60 of 124 articles · Check methods and identity

Clear search and filters

  • Check methods and identity

    How removing different numbers of residues changed a cell assay

    IGF-1 DES 1,3 refers to des(1–3)IGF-1, a 67-residue form lacking the first three amino acids of full-length IGF-1. An older experiment tested whether the number of removed residues changed the effect on protein production in a cell model.

    IGF-1 DES 1,31 source (1989)

  • Check methods and identity

    What a cultured ovarian-cell experiment measured about progesterone

    IGF-1 DES 1,3 refers here to des(1–3)IGF-1, a 67-amino-acid form missing the first three residues of full-length IGF-1. Researchers used the shortened molecule to ask how locally produced binding proteins influence a hormone response in cultured ovarian cells.

    IGF-1 DES 1,31 source (1992)

  • Check methods and identity

    How a liver-derived cell line helped test feedback on a binding protein

    IGF-DES 1,3 is used here for des(1–3)IGF-1, a 67-residue analogue lacking the first three amino acids of mature IGF-1. An older experiment asked whether the shortened form changes the amount of an IGF-binding protein produced by a liver-derived cell line.

    IGF-DES 1,31 source (1993)

  • Check methods and identity

    What an intestinal adaptation study measured after surgery in rats

    IGF-DES 1,3 commonly refers to des(1–3)IGF-1, the shortened form of insulin-like growth factor 1 missing its first three residues. What did an older animal study find when it compared the truncated and full-length forms after intestinal surgery?

    IGF-DES 1,32 sources (1989, 1992)

  • Check methods and identity

    Why protein measurements and glucose measurements diverged in a diabetes model

    IGF-DES 1,3 refers here to des(1–3)IGF-1, the form missing the first three residues of mature insulin-like growth factor 1. An animal experiment asked how the shortened variant affected protein metabolism in rats with experimentally induced diabetes.

    IGF-DES 1,32 sources (1989, 1991)

  • Check methods and identity

    What the IGF-2 LR3 Label Can Reliably Tell Us

    The name IGF-2 LR3 does not identify a confirmed sequence in the supplied catalog. It combines wording associated with two distinct research subjects: human IGF-II and Long R3 IGF-I. Both are useful to study. Neither can be assigned to an unidentified material by similarity of name.

    IGF-2 LR32 sources (1992, 2026)

  • Check methods and identity

    What a 2026 Placenta Study Measured About IGF2 and Birth Weight

    The label IGF-2 LR3 has not been matched to a defined material here. A study of native IGF2 in human tissue helps explain the biology of a related name, without establishing effects of that label.

    IGF-2 LR31 source (2026)

  • Check methods and identity

    What Studies of Defined IGF-II Variants Teach About Unclear Labels

    The catalog name IGF-2 LR3 is not enough to identify a verified variant. There are published experiments with other, explicitly named IGF-II variants. They are useful examples of how changing a known molecule can change its behavior, not substitutes for research on the unclear label.

    IGF-2 LR31 source (2025)

  • Check methods and identity

    What yeast production and a cell proliferation assay can establish

    IGF-LR3 is an 83-residue relative of human insulin-like growth factor 1 with an extension and an arginine substitution. One research question is how investigators test whether a recombinant preparation retains biological activity.

    IGF-LR32 sources (1992, 2023)

  • Check methods and identity

    What a placebo-controlled trial measured after bowel resection

    Ipamorelin is a synthetic five-residue agonist of the ghrelin receptor. A randomized trial asked whether it could help adults recover coordinated bowel function after part of the intestine was removed. No recent primary clinical trial replacing the older evidence for this question was identified.

    Ipamorelin2 sources (2014, 2024)

  • Check methods and identity

    How the original ipamorelin study tested receptor selectivity

    Ipamorelin is a synthetic five-residue peptide developed as a growth hormone secretagogue. Its original laboratory and animal experiments asked whether it would stimulate growth hormone release through the same receptor system as other secretagogues.

    Ipamorelin2 sources (1998, 2024)

  • Check methods and identity

    What the Four Ingredient KLOW Label Can Reliably Tell Us

    KLOW is a catalog name for a mixture, rather than the name of one defined peptide. The formulation described in the supplied catalog names BPC-157, TB-500, KPV and GHK-Cu. That list describes the intended ingredients.

    KLOW Blend4 sources (2026)

Browse by product

General topics

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice. Library index (JSON)